Hereditary pancreatitis screening: Difference between revisions

Jump to navigation Jump to search
 
(9 intermediate revisions by 2 users not shown)
Line 4: Line 4:
{{CMG}}; {{AE}}{{IQ}}  
{{CMG}}; {{AE}}{{IQ}}  
==Overview==
==Overview==
Patients with hereditary pancreatitis should be screened for [[pancreatic cancer]] as they are at markedly increased risk of [[pancreatic cancer]].


There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
==Screening==
==Screening==
*Patients with hereditary pancreatitis should be screened for pancreatic cancer.<ref name="pmid12120218">{{cite journal |vauthors=Ulrich CD |title=Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment |journal=Pancreatology |volume=1 |issue=5 |pages=416–22 |year=2001 |pmid=12120218 |doi= |url=}}</ref><ref name="pmid17872573">{{cite journal |vauthors=Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI |title=Advances in counselling and surveillance of patients at risk for pancreatic cancer |journal=Gut |volume=56 |issue=10 |pages=1460–9 |year=2007 |pmid=17872573 |pmc=2000231 |doi=10.1136/gut.2006.108456 |url=}}</ref>
*Patients with hereditary pancreatitis should be screened for [[pancreatic cancer]] as they are at markedly increased risk of [[Pancreatic cancer|pancreatic cancer.]]<ref name="pmid12120218">{{cite journal |vauthors=Ulrich CD |title=Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment |journal=Pancreatology |volume=1 |issue=5 |pages=416–22 |year=2001 |pmid=12120218 |doi= |url=}}</ref><ref name="pmid17872573">{{cite journal |vauthors=Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI |title=Advances in counselling and surveillance of patients at risk for pancreatic cancer |journal=Gut |volume=56 |issue=10 |pages=1460–9 |year=2007 |pmid=17872573 |pmc=2000231 |doi=10.1136/gut.2006.108456 |url=}}</ref><ref name="pmid15017610">{{cite journal |vauthors=Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley RM, Uomo G, Delhaye M, Spicak J, Drumm B, Jansen J, Mountford R, Whitcomb DC, Neoptolemos JP |title=Clinical and genetic characteristics of hereditary pancreatitis in Europe |journal=Clin. Gastroenterol. Hepatol. |volume=2 |issue=3 |pages=252–61 |year=2004 |pmid=15017610 |doi= |url=}}</ref><ref name="pmid18755888">{{cite journal |vauthors=Rebours V, Boutron-Ruault MC, Schnee M, Férec C, Le Maréchal C, Hentic O, Maire F, Hammel P, Ruszniewski P, Lévy P |title=The natural history of hereditary pancreatitis: a national series |journal=Gut |volume=58 |issue=1 |pages=97–103 |year=2009 |pmid=18755888 |doi=10.1136/gut.2008.149179 |url=}}</ref><ref name="pmid9091646">{{cite journal |vauthors=Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates LK, Perrault J, Whitcomb DC |title=Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group |journal=J. Natl. Cancer Inst. |volume=89 |issue=6 |pages=442–6 |year=1997 |pmid=9091646 |doi= |url=}}</ref><ref name="pmid10415865">{{cite journal |vauthors=Whitcomb DC, Applebaum S, Martin SP |title=Hereditary pancreatitis and pancreatic carcinoma |journal=Ann. N. Y. Acad. Sci. |volume=880 |issue= |pages=201–9 |year=1999 |pmid=10415865 |doi= |url=}}</ref>
*According to 2001 guidelines, screening for pancreatic cancer should begin at age 40.
*According to 2001 guidelines, screening for [[pancreatic cancer]] should begin at age 40.<ref name="pmid12120218">{{cite journal |vauthors=Ulrich CD |title=Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment |journal=Pancreatology |volume=1 |issue=5 |pages=416–22 |year=2001 |pmid=12120218 |doi= |url=}}</ref>
*In 2007, The Fourth Annual Symposium of Inherited Diseases of the Pancreas recommended the screening age for pancreatic cancer in patients with hereditary pancreatitis or those at increased risk to be (whichever is at the earliest age)
*In 2007, The Fourth Annual Symposium of Inherited Diseases of the Pancreas recommended the screening age for pancreatic cancer in patients with hereditary pancreatitis or those at increased risk to be (whichever is at the earliest age)<ref name="pmid17872573">{{cite journal |vauthors=Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI |title=Advances in counselling and surveillance of patients at risk for pancreatic cancer |journal=Gut |volume=56 |issue=10 |pages=1460–9 |year=2007 |pmid=17872573 |pmc=2000231 |doi=10.1136/gut.2006.108456 |url=}}</ref>
**45 year old or
**Starting 15 years earlier than the youngest age of [[pancreatic cancer]] in the family (whichever is at the earliest age)


**45 year old
* Patients with hereditary pancreatitis are usually recommended for yearly screening for pancreatic exocrine and [[Endocrine disorders|endocrine insufficiency]].
or
**Starting 15 years younger than the earliest age of pancreatic cancer in the family (whichever is at the earliest age)


==References==
==References==

Latest revision as of 15:29, 31 January 2018

Hereditary pancreatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hereditary pancreatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Hereditary pancreatitis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hereditary pancreatitis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hereditary pancreatitis screening

CDC on Hereditary pancreatitis screening

Hereditary pancreatitis screening in the news

Blogs on Hereditary pancreatitis screening

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Hereditary pancreatitis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]

Overview

Patients with hereditary pancreatitis should be screened for pancreatic cancer as they are at markedly increased risk of pancreatic cancer.

Screening

  • Patients with hereditary pancreatitis should be screened for pancreatic cancer as they are at markedly increased risk of pancreatic cancer.[1][2][3][4][5][6]
  • According to 2001 guidelines, screening for pancreatic cancer should begin at age 40.[1]
  • In 2007, The Fourth Annual Symposium of Inherited Diseases of the Pancreas recommended the screening age for pancreatic cancer in patients with hereditary pancreatitis or those at increased risk to be (whichever is at the earliest age)[2]
    • 45 year old or
    • Starting 15 years earlier than the youngest age of pancreatic cancer in the family (whichever is at the earliest age)
  • Patients with hereditary pancreatitis are usually recommended for yearly screening for pancreatic exocrine and endocrine insufficiency.

References

  1. 1.0 1.1 Ulrich CD (2001). "Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment". Pancreatology. 1 (5): 416–22. PMID 12120218.
  2. 2.0 2.1 Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI (2007). "Advances in counselling and surveillance of patients at risk for pancreatic cancer". Gut. 56 (10): 1460–9. doi:10.1136/gut.2006.108456. PMC 2000231. PMID 17872573.
  3. Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley RM, Uomo G, Delhaye M, Spicak J, Drumm B, Jansen J, Mountford R, Whitcomb DC, Neoptolemos JP (2004). "Clinical and genetic characteristics of hereditary pancreatitis in Europe". Clin. Gastroenterol. Hepatol. 2 (3): 252–61. PMID 15017610.
  4. Rebours V, Boutron-Ruault MC, Schnee M, Férec C, Le Maréchal C, Hentic O, Maire F, Hammel P, Ruszniewski P, Lévy P (2009). "The natural history of hereditary pancreatitis: a national series". Gut. 58 (1): 97–103. doi:10.1136/gut.2008.149179. PMID 18755888.
  5. Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates LK, Perrault J, Whitcomb DC (1997). "Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group". J. Natl. Cancer Inst. 89 (6): 442–6. PMID 9091646.
  6. Whitcomb DC, Applebaum S, Martin SP (1999). "Hereditary pancreatitis and pancreatic carcinoma". Ann. N. Y. Acad. Sci. 880: 201–9. PMID 10415865.

Template:WH Template:WS